Ceridian HCM (CDAY) Tops Q3 EPS by 7c

Ceridian HCM (NYSE: CDAY) reported Q3 EPS of $0.12, $0.07 better than the analyst estimate of $0.05. Revenue for the quarter came in at $204.4 million versus the consensus estimate of $200.39 million.

GUIDANCE:

Ceridian HCM sees Q4 2020 revenue of $215-219 million, versus the consensus of $222 million.

For earnings history and earnings-related data on Ceridian HCM (CDAY) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating